Dobutamine as palliative drug in home-care advanced cancer patients.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 7529813.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient with advanced cancer whose severe symptoms of congestive heart failure were successfully treated with dobutamine. The intermittent intravenous administration of dobutamine 5 micrograms/kg/min for 3 hr per day at home enabled control of dyspnea, leg edema, and pain, and increased urine output after 1 day. An improvement in renal function was observed in the following days. The mechanism and the utility of a palliative approach with dobutamine are discussed.
Medical subject headings
- Dobutamine
- Heart Failure
- Home Care Services
- Neoplasms
- Palliative Care